ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Valuerich,

Valuerich, (IVA)

0.00
0.00
(0.00%)
Closed November 24 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

IVA Latest News

Inventiva annonce sa participation Γ  deux confΓ©rences investisseurs

Regulatory News: Inventiva (Paris:IVA), sociΓ©tΓ© biopharmaceutique spΓ©cialisΓ©e dans le dΓ©veloppement de traitements innovants, notamment contre la fibrose, annonce aujourd’hui que...

Inventiva : information financière du 3ème trimestre 2017

TrΓ©sorerie au 30 septembre 2017 augmentΓ©e Γ  64,9 M€ contre 64,4 M€ au 30 juin 2017 Chiffre d’affaires de 6,0 M€ en croissance de + 4,6% Regulatory News: Inventiva...

Inventiva finalise le recrutement de son Γ©tude de Phase IIb FASST Γ©valuant lanifibranor dans la sclΓ©rodermie systΓ©mique

Fin du recrutement avec 145 patients randomisΓ©s Recrutement rΓ©alisΓ© dans 47 centres cliniques et 10 pays Principaux rΓ©sultats attendus dΓ©but 2019 Regulatory News: Inventiva...

InventivaΒ : rΓ©sultats du 1er semestre 2017

Fin du recrutement de l’étude de Phase IIb FASST avec lanifibranor dans la sclΓ©rodermie systΓ©mique prΓ©vu d’ici le 4Γ¨me trimestre 2017 Extension Γ  d’autres sites cliniques pour...

Inventiva : l’Organisation Mondiale de la SantΓ© (OMS) attribue Γ  IVA337 la dΓ©nomination de « lanifibranorΒ Β»

Lanifibranor (anciennement IVA337) est le premier agoniste panPPAR Ξ±, Ξ΄ et Ξ³ de nouvelle gΓ©nΓ©ration Γ  obtenir le suffixe « fibranorΒ Β» Candidat-mΓ©dicament le plus avancΓ© d’Inventiva...

Inventiva annonce l’exercice par Boehringer Ingelheim de son option pour dΓ©velopper conjointement de nouveaux traitements ...

L’exercice de cette option fait suite Γ  la validation d’une nouvelle cible pour le traitement de la fibrose et dΓ©clenche le versement d’un paiement de 2,5 millions d’euros Γ  Inventiva...

Inventiva et AbbVie Γ©tendent leur collaboration pour dΓ©couvrir de nouveaux candidats-mΓ©dicaments oraux antagonistes de ROR...

Regulatory News: Inventiva (Paris:IVA), sociΓ©tΓ© biopharmaceutique spΓ©cialisΓ©e dans le dΓ©veloppement de traitements innovants, notamment contre la fibrose, annonce aujourd’hui...

Odiparcil d’Inventiva reΓ§oit la dΓ©signation de mΓ©dicament orphelin par l’Agence europΓ©enne des mΓ©dicaments pour le t...

La dΓ©signation de mΓ©dicament orphelin a Γ©tΓ© reΓ§ue de la FDA plus tΓ΄t ce mois-ci Les dΓ©signations de mΓ©dicament orphelin de l’EMA et de la FDA valident le potentiel d’odiparcil pour...

Inventiva : Odiparcil reçoit la désignation de médicament orphelin par la FDA américaine dans le traitement de la MPS VI

Confirmation du potentiel thΓ©rapeutique et du bΓ©nΓ©fice d’odiparcil comparΓ© aux options thΓ©rapeutiques existantes Odiparcil pourrait amΓ©liorer significativement le traitement des...

Inventiva présentera des nouveaux résultats sur IVA337 lors du 15e congrès scientifique International Workshop on Sclerode...

L’abstract sur IVA337 sΓ©lectionnΓ© parmi les meilleurs articles du congrΓ¨s IVA337 prΓ©serve la fonction pulmonaire et confirme son potentiel comme traitement curatif de la sclΓ©rodermie...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VINEFresh Vine Wine Inc
$ 0.8246
(28.86%)
2.1M
UMACUnusual Machines Inc
$ 4.76
(24.93%)
461.87k
CATXPerspective Therapeutics Inc
$ 3.495
(16.50%)
10.43M
TPETTrio Petroleum Corp
$ 1.35
(15.38%)
909.2k
MSTUT Rex 2X Long MSTR Daily Target ETF
$ 209.77
(13.69%)
10.42M
LCTXLineage Cell Therapeutics Inc
$ 0.50325
(-16.13%)
15.61M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 0.9467
(-11.52%)
808.14M
FOXOFOXO Technologies Inc
$ 0.53
(-11.50%)
2.32M
BOILProShares Ultra Bloomberg Natural Gas New
$ 45.555
(-11.34%)
4.2M
DDCDDC Enterprise Limited
$ 0.1825
(-8.75%)
645.72k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 0.9467
(-11.52%)
808.14M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.22
(6.62%)
56.76M
FXIiShares China Large Cap
$ 29.69
(-2.17%)
54.61M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 28.49
(0.00%)
51.86M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 6.035
(-0.74%)
49.97M

IVA Discussion

View Posts
Invest-in-America Invest-in-America 1 month ago
IVA: WOW!! They got huuuuuge new "FINANCING"?? Sure!!! Vis-a-vis merely DUMPING yet more shares to MARKET!!!! What a SCAM!!!
πŸ‘οΈ0
Awl416 Awl416 1 month ago
Dumb dumbs
πŸ‘οΈ0
bigbux1 bigbux1 2 years ago
What happened over here? Talk about a rocket launch!
πŸ‘οΈ0
loniee loniee 14 years ago
going to a stinky pinky...lol
http://ih.advfn.com/p.php?pid=nmona&article=45486693&symbol=IVA
πŸ‘οΈ0
loniee loniee 14 years ago
holy cow...teach me to pull it off of my screen..how the heck did I miss them .11's
πŸ‘οΈ0
THUMBS THUMBS 14 years ago
ValueRich Substantially Increases Its Cash Position
Date : 07/16/2010 @ 2:56PM
Source : Business Wire
Stock : ValueRich, Inc. (IVA)
Quote : 0.19 -0.01 (-5.00%) @ 2:43PM

ValueRich, Inc. (NYSE Amex: IVA) announced today that the Company has substantially increased its cash position due to the sale of one of its single-family home lots and also the release of funds back to ValueRich that secured a performance bond to satisfy an outstanding wetland mitigation issue with the South Florida Water Management District. The finished lot was sold for $300,000 and was one (1) of eighty-two (82) single-family home lots ValueRich acquired with its original purchase of the Tesoro Preserve Development assets. ValueRich also received approximately $540,000 in funds released from an escrow account that was held to guarantee the resolution of an outstanding wetland mitigation issue located within the Tesoro Preserve Development that was not satisfied by the original developer. ValueRich engaged Culpepper and Terpening, Inc. and RL Weigt Environmental Consultants to complete the engineering and environmental work and the Company purchased 3.3 off site wetland mitigation credits from Bluefield Ranch Mitigation Bank in order to bring the Tesoro Preserve development into regulatory compliance with the South Florida Water Management District.

β€œAdding over $750,000 in cash to our balance sheet gives us the ability to continue investing in undervalued real estate. We continue to further develop our relationships with the banks that hold a substantial portion of the non-performing notes and assets associated with the real estate in Tesoro Preserve. This infusion of cash should provide ValueRich with the funding needed to buy additional finished single family home lots at favorable prices,” said Joseph Visconti, president and CEO of ValueRich, Inc.

About ValueRich, Inc.

ValueRich is engaged in the Investment, development and management of real estate assets located in Port St. Lucie, Florida. In early January of 2010 ValueRich and its wholly owned subsidiaries acquired Tesoro Preserve Development assets located in Port St. Lucie, Florida. The Tesoro Preserve Development is a private 350-acre community with 440 individual home sites. Included in the asset purchase was six (6) waterfront single-family residential lots, seventy-six (76) single family residential lots, approximately seven (7) acres of commercially zoned land adjacent to the residential community and certain improvements, personal property, intangible Property, development rights, and a builder’s royalty program.

This press release contains statements, which may constitute ``forward-looking statements'' within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995.

The forward-looking statements are based on current expectations, estimates and projections made by management. The Company intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, statements regarding our ability to engage in future real estate purchases. All forward-looking statements in this press release are made as of the date of this press release, and the Company assumes no obligation to update these forward-looking statements other than as required by law. Changing markets and various factors could make it more difficult to purchase property at favorable prices and the risk factors discussed in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Copies of these filings are available at www.sec.gov.




πŸ‘οΈ0
THUMBS THUMBS 15 years ago
LOL, been awhile
πŸ‘οΈ0
loniee loniee 15 years ago
edit...bring it
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
cool,hope they load&run it lol
πŸ‘οΈ0
loniee loniee 15 years ago
She suire is being accumulated by someone.it seems
πŸ‘οΈ0
loniee loniee 15 years ago
some weird trading here today..I wounder if they are still buying back...this is how it did before when they where...about twice a week..
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
bring it lon!
πŸ‘οΈ0
loniee loniee 15 years ago
Getting some volume today
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
not today
πŸ‘οΈ0
loniee loniee 15 years ago
they played right up to ya yesterday and cut in line on you..
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
bid in again,maybe ill get'em today
πŸ‘οΈ0
loniee loniee 15 years ago
someone cut in line...lol
πŸ‘οΈ0
loniee loniee 15 years ago
cool...thats nuts its down here and I don't see IVA letting it stay down here..600k of restricted shares was part of that deal so I am sure there was something said to get the pps up to use that as part of the deal.JMO
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
bidding for 2k more @.1799 lol
πŸ‘οΈ0
loniee loniee 15 years ago
this is nuts to be down here IMHO..
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
thanks lon,diggin my feet in good here.
will be posting more info as i can,new ibox comin as well
πŸ‘οΈ0
loniee loniee 15 years ago
Here is a link for the last 10Q easier to read here
http://ih.advfn.com/p.php?pid=nmona&cb=1264301091&article=40440344&symbol=A%5EIVA

This is interesting
http://www.wallstreethdtv.com/
πŸ‘οΈ0
loniee loniee 15 years ago
Looks like most of their dealsa are done in cash...I like this low O/S also...IMO way under valued...Now with all them lot ...wow
πŸ‘οΈ0
loniee loniee 15 years ago
Here is their 10Q



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

(Mark One)
x Quarterly report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2009
o Transition report pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______ to _______.

Commission file number 000-52404

VALUERICH, INC.
(Exact name of registrant as specified in its Charter)

Delaware
(State or other jurisdiction of incorporation or organization) 41-2102385
(I.R.S. Employer Identification No.)


1804 N. Dixie Highway, Suite A
West Palm Beach, Florida 33407
(Address of principal executive offices) (Zip Code)

1-561-370-3617
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x ? No o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o ? No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of β€œlarge accelerated filer,” β€œaccelerated filer” and β€œsmaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer o Accelerated filer o
Non-accelerated filer o
(Do not check if a smaller reporting company) Smaller reporting company x


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o ? No x


As of November 13, 2009, the Company had outstanding 8,669,670 shares of common stock, par value $0.01.




--------------------------------------------------------------------------------



TABLE OF CONTENTS


Part I – FINANCIAL INFORMATION 3
Item 1. Financial Statements 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
Item 3. Quantitative and Qualitative Disclosures About Market Risk 23
Item 4. Controls and Procedures 23
PART II - OTHER INFORMATION 24
Item 1. Legal Proceedings 24
Item 1A. Risk Factors 24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24
Item 3. Defaults Upon Senior Securities 24
Item 4. Submission of Matters to a Vote of Security Holders 24
Item 5. Other Information 24
Item 6. Exhibits 24
SIGNATURES 25




2

--------------------------------------------------------------------------------



Part I – FINANCIAL INFORMATION
Item 1. Financial Statements

VALUERICH, Inc.
CONDENSED BALANCE SHEETS
AS OF SEPTEMBER 30, 2009 AND DECEMBER 31, 2008

September 30,
2009 December 31,
2008
ASSETS (unaudited)

CURRENT ASSETS
Cash and cash equivalents $ 1,282,915 $ 920,908
Trade accounts receivable - 1,713
Prepaid consulting - 23,333
Investments in marketable securities 647,372 1,957,993
Other current assets 10,971 -

TOTAL CURRENT ASSETS 1,941,258 2,903,947

PROPERTY AND EQUIPMENT, net of accumulated depreciation 432,377 113,547

TOTAL ASSETS $ 2,373,635 $ 3,017,494


LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
Accounts payable and accrued expenses $ 214,416 $ 240,757
Deferred revenue 22,500 45,000
Convertible note payable 25,000 25,000
Shareholder note payable - 9,500

TOTAL CURRENT LIABILITIES 261,916 320,257

STOCKHOLDERS' EQUITY
Common stock; $0.01 par value; 100,000,000 shares authorized;
8,669,670 shares issued and outstanding as
of September 30, 2009 and December 31, 2008, respectively 86,696 86,696
Additional paid-in capital 7,194,184 7,175,789
Accumulated other comprehensive income 24,000 108,000
Accumulated deficit (5,193,161 ) (4,673,248 )

TOTAL STOCKHOLDERS' EQUITY 2,111,719 2,697,237
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,373,635 $ 3,017,494


See attached unaudited notes to financial statements



3

--------------------------------------------------------------------------------



VALUERICH, Inc.
CONDENSED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE LOSS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008

Three Months Ended
September 30, Nine Months Ended
September 30,
2009 2008 2009 2008
(unaudited) (unaudited)

REVENUE $ 15,500 $ 89,950 $ 83,762 $ 89,950

COST OF REVENUE - 1,560 - 7,876

GROSS PROFIT 15,500 88,390 83,762 82,074

OPERATING EXPENSES
Salaries and wages 57,165 72,928 306,285 333,122
Selling, general and administrative expenses 93,843 65,147 222,027 192,048
Professional fees 23,416 142,532 190,540 455,963
Depreciation and amortization expense 12,685 8,992 37,506 19,315

TOTAL OPERATING EXPENSES 187,109 289,599 756,358 1,000,448

LOSS FROM OPERATIONS (171,609 ) (201,209 ) (672,596 ) (918,374 )

OTHER INCOME (EXPENSES):
Dividend and interest income, net 13,753 17,696 53,626 89,187
Unrealized gain (loss) on marketable securities 73,503 - 2,310 -
Realized gain on marketable securities - - 73,150 -
Other income 11,221 (4,000 ) 23,597 19,626

TOTAL OTHER INCOME (EXPENSES) 98,477 13,696 152,683 108,813

LOSS BEFORE PROVISION FOR INCOME TAXES (73,132 ) (187,513 ) (519,913 ) (809,561 )

INCOME TAX BENEFIT - - - -

NET LOSS $ (73,132 ) $ (187,513 ) $ (519,913 ) $ (809,561 )

OTHER COMPREHENSIVE LOSS
Unrealized gain (loss) on available for sale securities 8,000 - (84,000 ) -

COMPREHENSIVE LOSS (65,132 ) (187,513 ) (603,913 ) (809,561 )

NET LOSS PER SHARE - BASIC AND DILUTED $ (0.01 ) $ (0.02 ) $ (0.06 ) $ (0.10 )

WEIGHTED AVERAGE COMMON EQUIVALENT
SHARES OUTSTANDING - BASIC AND DILUTED 8,669,670 8,566,542 8,669,670 8,470,228


See attached unaudited notes to financial statements



4

--------------------------------------------------------------------------------



VALUERICH, Inc.
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(UNAUDITED)



Common Stock

Shares Amount Additional
Paid-in
Capital Accumulated
Other
Comprehensive
Income Accumulated
Deficit Total
Stockholders'
Equity

Balance, December 31, 2008 8,669,670 86,696 7,175,789 108,000 (4,673,248 ) 2,697,237

Value of warrants granted for consulting services 18,395 18,395
Unrealized loss on marketable securities (84,000 ) (84,000 )
Net loss for period (519,913 ) (519,913 )

Balance, September 30, 2009 8,669,670 $ 86,696 $ 7,194,184 $ 24,000 $ (5,193,161 ) $ 2,111,719


See attached unaudited notes to financial statements




5

--------------------------------------------------------------------------------





VALUERICH, Inc.
CONDENSED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008
(UNAUDITED)

Nine Months Ended September 30,
2009 2008
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss $ (519,913) $ (809,561)
Adjustment to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization 37,506 19,314
Unrealized loss on marketable securities (2,310) -
Realized gain on marketable securities (88,881) -
Marketable securities received for consulting services 18,395 (60,000)
Value of warrants granted for consulting services -
Common stock issued for consulting services 88,500
Changes in operating assets and liabilities:
Trade accounts receivable 1,713 -
Prepaid expenses 23,333 29,889
Other current assets (10,971) (12,089)
Accounts payable and accrued expenses (26,341) (88,726)
Customer deposits - (1,400)
Deferred revenue (22,500) -

Net cash used in operating activities (589,969) (834,073)

CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of fixed assets (356,336) (71,637)
Purchase of intangible assets - (44,640)
Purchases of marketable securities (929,423) -
Proceeds from sale of marketable securities 2,247,235 -

Net cash provided by (used in) investing activities 961,476 (116,277)

CASH FLOW FROM FINANCING ACTIVITIES:
Repayments of notes payable (9,500) (70,000)

Net cash used in financing activities (9,500) (70,000)

NET INCREASE (DECREASE) IN CASH AND
CASH EQUIVALENTS 362,007 (1,020,350)

CASH AND CASH EQUIVALENTS, Beginning of period 920,908 3,568,535

CASH AND CASH EQUIVALENTS, End of period $ 1,282,915 $ 2,548,185

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid $ 2,500 $ -
Income taxes paid $ - $ -

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING:
Non-cash stock issuance $ - $ 88,500


See attached unaudited notes to financial statements






6

--------------------------------------------------------------------------------









VALUERICH, Inc.
CONDENSED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008
(UNAUDITED)


Note 1 - Organization and Basis of Presentation


The accompanying unaudited condensed financial statements have been prepared by ValueRich, Inc. (the β€œCompany”) in accordance with generally accepted accounting principles for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, these condensed financial statements do not include all of the disclosures required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the unaudited interim condensed financial statements furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the results for the interim period presented. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company's audited financial statements and notes included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2008. Operating results for the nine months ended September 30, 2009 are not necessarily indicative of the results that may be expected for the year ending December 31, 2009.


Note 2 – Summary of Significant Accounting Policies


Use of Estimates


The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements. The Company bases its estimates on historical experience, management expectations for future performance, and other assumptions as appropriate. Key areas affected by estimates include the assessment of the recoverability of long-lived assets, which is based on such factors as estimated future cash flows. The Company re-evaluates its estimates on an ongoing basis; actual results may vary from those estimates.


Concentration of Credit Risk


Cash includes cash on hand and demand deposits in accounts maintained within the United States. Certain financial instruments, which subject the Company to concentration of credit risk, consist of cash. The Company maintains balances at financial institutions which, from time to time, may exceed Federal Deposit Insurance Corporation (β€œFDIC”) insured limits for the banks located in the Unites States. As of September 30, 2009 and December 31, 2008, the Company had deposits in excess of FDIC limits totaling $1,282,915 and $782,283, respectively. The Company has not experienced any losses in such accounts.


Cash and Cash Equivalents


Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.


Marketable Securities


The Company has designated its investments in marketable securities as trading and available-for-sale. Marketable securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Marketable equity securities not classified as trading are classified as available for sale, and are carried at fair market value, with the unrealized gains and losses, net of tax, included in the determination of comprehensive income and reported in shareholders’ equity. Investment income is recognized on an accrual basis.


7

--------------------------------------------------------------------------------




The fair value of all securities is determined by quoted market prices. The estimated fair value of securities for which there are no quoted market prices is based on similar types of securities that are traded in the market.


Property, Plant and Equipment


Property and equipment are stated at historical cost and are depreciated using the straight-line method over their estimated useful lives. The useful life and depreciation method are reviewed periodically to ensure that the depreciation method and period are consistent with the anticipated pattern of future economic benefits. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses on disposals are included in the results of operations.


The Company provides for depreciation over the assets’ estimated lives as follows:


Computers, software and equipment 3 years
Furniture and fixtures 5 years
Leasehold improvements Lesser of lease life or economic life



Long-Lived Assets


The Company follows FASB ASC 360-10, β€œProperty, Plant, and Equipment,” which established a β€œprimary asset” approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long-lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Through September 30, 2009, the Company had not experienced impairment losses on its long-lived assets.


Fair Value of Financial Instruments and Concentrations


On January 1, 2008, the Company adopted FASB ASC 820-10, β€œFair Value Measurements and Disclosures.” FASB ASC 820-10 defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

· Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.


· Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.


· Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.


The Company’s investments in marketable securities are carried at fair value totaling $647,372 and $1,957,993 at September 30, 2009 and December 31, 2008, respectively. The Company used Level 1 inputs for its valuation methodology as the securities’ quoted prices are publicly available.


8

--------------------------------------------------------------------------------




Fair Value
As of
September 30, 2009 Fair Value Measurements at
September 30, 2009
Using Fair Value Hierarchy
Assets Level 1 Level 2 Level 3
Investments in marketable securities $ 647,372 $ 647,372 - -



For the three months ended September 30, 2009 and 2008, the Company recognized net unrealized gains on its trading securities in its statements of operations in the amounts of $73,503 and $0, respectively. For the nine months ended September 30, 2009 and 2008, the Company recognized net unrealized gains on its trading securities in its statements of operations in the amounts of $2,310 and $0, respectively. For the three months ended September 30, 2009 and 2008, the Company recognized unrealized gains on its available-for-sale securities in its statements of stockholders’ equity in the amounts of $8,000 and $0, respectively. For the nine months ended September 30, 2009 and 2008, the Company recognized unrealized losses on its available-for-sale securities in its statements of stockholders’ equity in the amounts of $84,000 and $0, respectively.


The Company did not identify any other assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with FASB ASC 815.


In February 2007, the FASB issued FAS No. 159, β€œThe Fair Value Option for Financial Assets and Financial Liabilities,” now known as ASC Topic 825-10 β€œFinancial Instruments.” ASC Topic 825-10 permits entities to choose to measure many financial assets and financial liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. FASB ASC 825-10 is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007. The Company adopted FASB ASC 825-10 on January 1, 2008. The Company chose not to elect the option to measure the fair value of eligible financial assets and liabilities.


Revenue Recognition

Revenue is recognized in the period that services are provided. For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin (β€œSAB”) Topic 13. SAB Topic 13 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. Payments received in advance are deferred until the product is delivered or service is rendered.


In 2008, the Company has focused on the transition from its old line of financial media products including the ValueRich financial Expos and the ValueRich Magazine to web-based products such as www.WallStreetHDTV.com, the second generation of www.iValueRich.com and www.ValueRichTV.com , which was launched during the quarter ended June 30, 2009. The Company has not earned any revenue from its old line of financial media products during the nine months ended September 30, 2009. During 2008, the Company entered into two consulting agreements to assist foreign-based companies manage their financial statement reporting, regulatory and compliance issues in the United States. The Company does not recognize revenue on its consulting business until persuasive evidence of an arrangement exists, delivery has occurred (the Company has performed according to the terms of the consulting agreement), the selling price is fixed and determinable, and collectability is reasonably assured. See Note 3.


9

--------------------------------------------------------------------------------




Income Taxes


Income taxes are provided based upon the asset and liability method of accounting in accordance with FASB ASC 740, β€œIncome Taxes.” Pursuant to FASB ASC 740, the Company is required to compute deferred income tax assets for net operating losses carried forward. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be realized or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. Realizing of deferred tax assets is assessed throughout the year and a valuation allowance is recorded if necessary to reduce net deferred tax assets to the amount more likely than not to be realized. The potential benefits of net operating losses (β€œNOLs”) have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.


The Company has an NOL carry forward for income tax reporting purposes that may be offset against future taxable income. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Accordingly, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company is uncertain if they will ever be in a position to utilize the NOL carry forward. Accordingly, the potential tax benefits of the loss carry forward are offset by a valuation allowance of the same amount.


The Company is current in its filing of federal income tax returns. The Company believes that the statutes of limitations for its federal income tax returns are open for years after 2004. The Company is not currently under examination by the Internal Revenue Service or any other taxing authority.


Under FASB ASC 740, a tax position is recognized as a benefit only if it is β€œmore likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the β€œmore likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements.


The Company’s practice is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. At September 30, 2009 and December 31, 2008, the Company had no accrued interest or penalties.


Basic and Diluted Losses Per Share


Earnings per share is calculated in accordance with the FASB ASC 260, β€œEarnings Per Share.” Basic earnings per share is based upon the weighted average number of common shares outstanding. Diluted earnings per share is based on the assumption that all dilutive convertible shares and stock options were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. All dilutive securities were excluded from the diluted loss per share due to the anti-diluted effect.


The computation of earnings per share of common stock is based on the weighted average number of shares outstanding at the date of the financial statements.


10

--------------------------------------------------------------------------------




Three months ended Nine months ended
Loss
(Numerator) Shares
(Denominator) Per-Share
Amount Loss
(Numerator) Shares
(Denominator) Per-Share
Amount
September 30, 2009:
Basic and diluted EPS
Loss to common stockholders $ (73,132 ) 8,669,670 $ (0.01 ) $ (519,913 ) 8,669,670 $ (0.06 )
September 30, 2008:
Basic and diluted EPS
Loss to common stockholders $ (187,513 ) 8,566,542 $ (0.02 ) $ (809,561 ) 8,470,228 $ (0.10 )


As of September 30, 2009 and 2008, the following potential dilutive shares were excluded from diluted loss per share for all periods presented because of their anti-dilutive effect.


September 30 , 2009 September 30, 2008
Options 100,000 100,000
Warrants 1,235,715 591,429
Convertible notes 67,000 134,000
Total 1,402,715 825,429



Stock-Based Compensation


The Company accounts for its stock-based compensation in accordance with FASB ASC 718 β€œCompensation-Stock Compensation,” The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees, estimated using the Black-Scholes option pricing model. No options or warrants were exercised during the nine months ended September 30, 2009. During the nine months ended September 30, 2009, 0 warrants expired. During the nine months ended September 30, 2009, no new options were granted. During the nine months ended September 30, 2009, a warrant to purchase 50,000 shares of the Company’s common stock was granted. As of September 30, 2009, there were 1,235,715 warrants and 100,000 options outstanding, respectively.


Special Purpose Entities


The Company does not have any off-balance sheet financing activities.


Reclassification


Certain reclassifications have been made to the 2008 financial statements to conform to the 2009 financial statement presentation. These reclassifications had no effect on net income or cash flows as previously reported.


Recent Pronouncements


In May 2009, the FASB issued SFAS No. 165, β€œSubsequent Events” (β€œSFAS 165”) codified in FASB ASC 855-10-05, which provides guidance to establish general standards of accounting for and disclosures of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. FASB ASC 855-10-05 also requires entities to disclose the date through which subsequent events were evaluated as well as the rationale for why that date was selected. FASB ASC 855-10-05 is effective for interim and annual periods ending after June 15, 2009, and accordingly, the Company adopted this pronouncement during the second quarter of 2009. FASB ASC 855-10-05 requires that public entities evaluate subsequent events through the date that the financial statements are issued.


11

--------------------------------------------------------------------------------



In June 2009, the FASB issued SFAS No. 166, β€œAccounting for Transfers of Financial Assets β€” an amendment of FASB Statement No. 140” (β€œSFAS 166”), codified as FASB ASC 860, which requires entities to provide more information regarding sales of securitized financial assets and similar transactions, particularly if the entity has continuing exposure to the risks related to transferred financial assets. FASB ASC 860 eliminates the concept of a β€œqualifying special-purpose entity,” changes the requirements for derecognizing financial assets and requires additional disclosures. FASB ASC 860 is effective for fiscal years beginning after November 15, 2009. The adoption of FASB ASC 860 did not have an impact on the Company’s financial condition, results of operations or cash flows.


In June 2009, the FASB issued SFAS No. 167, β€œAmendments to FASB Interpretation No. 46(R)” (β€œSFAS 167”), codified as FASB ASC 810-10, which modifies how a company determines when an entity that is insufficiently capitalized or is not controlled through voting (or similar rights) should be consolidated. FASB ASC 810-10 clarifies that the determination of whether a company is required to consolidate an entity is based on, among other things, an entity’s purpose and design and a company’s ability to direct the activities of the entity that most significantly impact the entity’s economic performance. FASB ASC 810-10 requires an ongoing reassessment of whether a company is the primary beneficiary of a variable interest entity. FASB ASC 810-10 also requires additional disclosures about a company’s involvement in variable interest entities and any significant changes in risk exposure due to that involvement. FASB ASC 810-10 is effective for fiscal years beginning after November 15, 2009. The adoption of FASB ASC 810-10 did not have an impact on the Company’s financial condition, results of operations or cash flows.


In June 2009, the FASB issued FASB ASC 105, Generally Accepted Accounting Principles, which establishes the FASB Accounting Standards Codification as the sole source of authoritative generally accepted accounting principles. Pursuant to the provisions of FASB ASC 105, the Company has updated references to GAAP in its financial statements issued for the period ended September 30, 2009. The adoption of FASB ASC 105 did not impact the Company’s financial position or results of operations.


Note 3 – Consulting Agreement with Bodisen Biotech


Effective July 1, 2008 and continuing for a period of 2 years, the Company was engaged to perform strategic business consulting services to Bodisen Biotech. As compensation for the consulting services, Bodisen Biotech has agreed to:


(a) Issue to the Company 400,000 shares of Bodisen Biotech common stock to the Company up front;

(b) Issue to the Company options to purchase 400,000 shares of its common stock. The options will be exercisable at $0.70 per share and will have an exercise period of 5 years;

(c) Pay the Company $10,000 per month for the 24-month consulting period, equaling a total of $120,000 per year.



The Company recorded $60,000 in marketable securities and corresponding revenue for the 400,000 shares received on September 18, 2008. The marketable securities have been classified as available-for-sale. These securities are carried at fair value with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholder's equity. See Note 4.


The Company has valued the options received under the consulting agreement using the Black-Scholes option pricing model. The option exercise price is $0.70 per share. The fair value of the options was $25,800 and the following assumptions: term of 2.5 years, a risk free interest rate of 2.1%, a dividend yield of 0% and volatility of 128%. Management has performed an analysis and determined the options are impaired at September 30, 2009, and therefore the Company has recorded a 100% allowance against the value of the options.


12

--------------------------------------------------------------------------------




For the nine months ended September 30, 2009, the Company has recognized $50,000, less wire fees, in consulting revenues relating to the cash component of its consulting compensation.


The consulting agreement was terminated by Bodisen Biotech on May 31, 2009, with no required further obligations by either party.


Note 4 – Marketable Securities


The Company invests its available operating funds primarily in high-yield mutual funds that hold common stock of U.S. companies with large market capitalizations. The Company also invests in common stock of U.S. companies with large market capitalizations. Management’s objective is to identify common stocks and mutual funds with holdings that are under-valued with potential for short-term (under one-year holding period) appreciation. The Company’s marketable securities consist of trading and available-for-sale securities, all of which are classified as marketable securities and are carried at their fair value based on the quoted market prices of the securities at September 30, 2009 and December 31, 2008. Net unrealized gains and losses on trading securities are included in the statements of operations and other comprehensive loss. Available-for sale securities consist of the 400,000 shares received in July 2008 for consulting services performed for Bodisen Biotech (see Note 3). These securities are carried at fair value with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive income (loss), a separate component of stockholder's equity. The investment in these shares has been valued at $84,000 at September 30, 2009 and, accordingly a $24,000 unrealized gain has been recognized in accumulated other comprehensive income at September 30, 2009 in the accompanying balance sheets. Realized gains and losses on trading and available-for-sale securities are included in net earnings in the period earned or incurred. For purpose of determining realized gains and losses, the cost of securities sold is based on specific identification.


The composition of marketable securities, classified as current assets, is as follows at September 30, 2009 and December 31, 2008.

September 30, 2009
Cost Gross Unrealized
Gains Gross Unrealized
Losses Fair Value
Available-for-sale securities $ 60,000 $ 24,000 $ - $ 84,000

Mutual Funds 418,447 84,175 - 502,621
Common Stock 27,489 33,261 - 60,751
Total marketable securities $ 505,936 141,436 $ - $ 647,372

December 31, 2008
Cost Gross Unrealized
Gains Gross Unrealized
Losses Fair Value
Available-for-sale securities $ 60,000 $ 108,000 $ - $ 168,000

Mutual Funds 1,249,431 97,927 (15,787 ) 1,331,571
Common Stock 421,497 41,303 (4,378 ) 458,422
Total marketable securities $ 1,730,928 $ 247,230 $ (20,165 ) $ 1,957,993 )




13

--------------------------------------------------------------------------------



Investment income for the three and nine months ended September 30, 2009 and 2008 consists of the following:

Three months ended Nine months ended
2009 2008 2009 2008
Gross realized gains from sale of trading securities $ - - $ 177,545 $ -
Gross realized losses from sale of trading securities - - (104,395 ) -
Dividend and interest income 13,753 - 53,626 -
Net unrealized holding gain 73,503 - 2,310 -
Net investment income $ 87,256 - $ 129,086 $ -


Management evaluates securities for other-than-temporary impairment at least on a yearly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to the length of time and amount of the loss relative to cost, the nature and financial condition of the issuer and the ability and intent of the Company to hold the investment for a time sufficient to allow any anticipated recovery in fair value. There were no securities with unrealized losses that management considers to be other-than-temporary impairments at September 30, 2009 and December 31, 2008.


Proceeds from the sale of investments in trading securities during the three months ended September 30, 2009 and 2008 were $0 and $0, respectively. Proceeds from the sale of investments in trading securities during the nine months ended September 30, 2009 and 2008 were $2,247,235 and $0, respectively.


Note 6 – Property and Equipment


Property and equipment consisted of the following at September 30, 2009 and December 31, 2008:

September 30,
2009 December 31,
2008
Building $ 225,682 $ -
Computers and equipment 140,848 31,859
Furniture and fixtures 33,427 29,366
Leasehold improvements 83,257 82,257
Website 71,745 55,140
554,959 198,622
Accumulated depreciation (122,582 ) (85,075 )
Fixed assets, net $ 432,377 $ 113,547


Depreciation expense amounted to $12,685 and $4,999 for the three months ended September 30, 2009 and 2008, respectively. Depreciation expense amounted to $37,506 and $11,847 for the nine months ended September 30, 2009 and 2008, respectively.


Note 7 – Accounts Payable and Accrued Expenses


Accrued expenses and other liabilities comprises of the following:

September 30,
2009 December 31,
2008
Accounts payable $ 199,584 $ 216,252
Accrued interest 6,750 6,000
Other accrued expenses 8,082 18,505
Total $ 214,416 240,757


Note 8 – Operating Lease and Other Commitments


In January 2009, the Company entered into a one year lease agreement with Joseph C. Visconti, CEO and President, to lease a 1,750 square foot office facility for $3,190 per month ($38,280 per year) commencing January 1, 2009 and terminating on December 31, 2009.


14

--------------------------------------------------------------------------------




Note 9 – Debt


The Company’s debt at September 30, 2009 and December 31, 2008 is detailed as follows:


September 30,
2009 December 31,
2008
Shareholders Notes Payable:
Notes payable to an individual 10% interest accrued,
Issued 12/03, Matures 5/09 $ - $ 9,500

Convertible Notes Payable:
Note payable to an individual 6% interest accrued,
Issued 10/04, convertible Matured 12/07 (in default) $ 25,000 25,000


In addition to the information stated above, other material terms of the convertible debt instruments include: 1) a conversion price of $0.60 per share; 2) a debt penalty to include the issuance of additional shares upon conversion totaling 10% of the shares into which the note may convert if the Company’s shares are not listed for public trading on or before October 1, 2004; and 3) a warrant to purchase the same number of shares into which the original principal amount could be converted at an exercise price of $2.00 per share. As the convertible note payable is in default at September 30, 2009, the Company has classified the note as short-term in its accompanying balance sheets.


The Company has adopted FASB ASC 470-20 β€œDebt – Debt with Conversion and Other Options.” During 2004 and 2005 we incurred debt with a conversion feature that provides for a rate of conversion, but with no trading market value there was no beneficial conversion feature to record.


The Company repaid $9,500 and $25,000 of its shareholder notes payable in cash during the nine months ended September 30, 2009 and 2008, respectively.


Note 10 – Equity


The Company did not issue shares of its common stock during the nine months ended September 30, 2009.


Note 11 – Warrants


On March 19, 2009, the Company granted a warrant to purchase 50,000 shares of its common stock at $0.25 per share in connection with consulting services. The warrant was valued at $18,395 using the Black-Scholes pricing model with the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 184%; (3) risk-free interest rate of 0.87%, and expected life of 2 years. The amount was recorded to professional fees in the accompanying statement of operations and comprehensive loss for the nine months ended September 30, 2009.


The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company’s common stock issued to non-employees of the Company. These warrants were granted in connection with the convertible shareholder notes payable and for consulting services.


15

--------------------------------------------------------------------------------




A summary of warrant activity for the nine months ended September 30, 2009 is presented below:

Number of
Warrants Weighted
Average
Exercise
Price Weighted
Average
Remaining
Contractual
Life (in years) Aggregate
Intrinsic
Value
(000)
Outstanding, January 1, 2008 2,376,494 $ 2.00 0.37 $ -
Granted 200,000 0.55
Exercised - -
Expired (1,390,779 ) 1.89
Outstanding, December 31, 2008 1,185,715 1.61 2.59 -

Exercisable, December 31, 2008 1,185,715 1.61 2.59 -

Outstanding, January 1, 2009 1,185,715 1.61 2.59 -
Granted 50,000 0.25
Exercised - -
Expired - -
Outstanding, September 30, 2009 1,235,715 1.55 1.82 13

Exercisable, September 30, 2009 1,235,715 $ 1.55 1.82 $ 13


The aggregate intrinsic value in the table above is before applicable income taxes and is calculated based on the difference between the exercise price of the warrants and the quoted price of the Company’s common stock as of the reporting date.


Note 11 – Related Party Transactions


The Company leases a 1,750 square foot office facility at $3,190 per month ($38,280 per year) from Joseph C. Visconti CEO and President. See Note 8.


Various shareholders have made loans to the company. At December 31, 2008, one shareholder note was outstanding for $9,500 which was repaid in full during the nine months ended September 30, 2009. See Note 9.


Note 13 – Subsequent Events


In November 2009, the Company transferred 280,000 of the 400,000 shares of it’s available for sale security in Bodisen Biotech to a third party consultant for services rendered.


16

--------------------------------------------------------------------------------



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations


This discussion and analysis should be read in conjunction with the accompanying Condensed Financial Statements and related notes. Our discussion and analysis of our financial condition and results of operations are based upon our condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. On an on-going basis we review our estimates and assumptions. Our estimates are based on our historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions. Our critical accounting policies, the policies we believe are most important to the presentation of our financial statements and require the most difficult, subjective and complex judgments, are outlined below in β€˜β€˜Critical Accounting Policies,’’ and have not changed significantly.


FORWARD-LOOKING STATEMENTS



Certain statements made in this report may constitute β€œforward-looking statements on our current expectations and projections about future events ”. These forward-looking statements involve known or unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases you can identify forward-looking statements by terminology such as β€œmay,” β€œshould,” β€œpotential,” β€œcontinue,” β€œexpects,” β€œanticipates,” β€œintends,” β€œplans,” β€œbelieves,” β€œestimates,” and similar expressions. These statements are based on our current beliefs, expectations, and assumptions and are subject to a number of risks and uncertainties. Although we believe that the expectations reflected-in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. These forward-looking statements are made as of the date of this report, and we assume no obligation to update these forward-looking statements whether as a result of new information, future events, or otherwise, other than as required by law. In light of these assumptions, risks, and uncertainties, the forward-looking events discussed in this report might not occur and actual results and events may vary significantly from those discussed in the forward-looking statements .


General


The following discussion and analysis should be read in conjunction with our financial statements and related footnotes for the year ended December 31, 2008 included in our Form 10K/A for the year ended December 31, 2008 filed with the Securities and Exchange Commission. The discussion of results, causes and trends should not be construed to imply any conclusion that such results or trends will necessarily continue in the future.


Our Corporate History


ValueRich, Inc., (the Company), was incorporated under the laws of the state of Florida on July 11, 2003 and reincorporated in Delaware on March 3, 2006. The Company owns various online and offline media-based properties for corporate and financial professionals. Its properties include 1) iValueRich.com, 2) ValueRich magazine and 3) the ValueRich Small-cap Financial Expo. iValueRich.com is an online community providing a range of business solutions for public companies and the many industry related businesses and professionals that seek to do business with each other. The small-cap financial expo is a unique expo-style financial conference format for small-cap public companies to showcase their products and services and have continuous access to investment bankers and buy-side professionals.


17

--------------------------------------------------------------------------------



We have a limited operating history. We launched iValuerich.com in June 2006, we hosted our first financial expo in March 2005, and we published our first edition of ValueRich magazine in the spring of 2004. During our limited operating history, we have not been profitable. For the nine months ended September 30, 2009, we incurred a net loss and comprehensive loss of $519,913 and $603,913, respectively.

Our corporate mission is to create an active community of Wall Street professionals and small-cap public company executives. To accomplish this we will use our online and offline properties, including our global Internet community, print publishing and financial events to connect the corporate and financial professionals that make up the securities industry. We seek to accomplish this through our integrated portfolio of products and services that we now provide for the small public capitalization market place.


Results of Operations


Our results of operations for the three and nine months ended September 30, 2009 have been significantly impacted by our decision to revise our financial expo line of business to be a co-branded or partnered expo in response to increased competition we have experienced in the financial convention space. Since we were unable until the mid-second quarter 2008 to find a suitable partner to co-brand or partner our expos, we did not have any expo events during 2008 as we had planned, and therefore we did not derive any revenue from expos during 2008.


Throughout 2008, we have focused on the transition of our old line financial media products including the ValueRich financial Expos and the ValueRich Magazine to web-based products such as www.WallStreetHDTV.com, the second generation of www.iValueRich.com and www.ValueRichTV.com , which was launched during the nine months ended September 30, 2009.


By the first quarter of 2009, we had launched the second generation of the ValueRich platform, which added a full spectrum of financial and web-based tools for small-cap companies seeking to go public and raise capital via a web-based Direct Offering (β€œDO”) format. Companies that want to raise capital could file their own registration statement through the DO process and pay us for the use of our technology platform and access to our financial related professionals to assist in funding the issuing company’s deal. For the first time, users of the ValueRich technology platform who have verified their qualified investor’s status will be able to discover and participate in Direct Offerings featured on the ValueRich platform. While we are not a registered broker-dealer or investment advisor, soon we will be able to provide companies with technology and marketing tools they need to communicate directly with qualified investors.


During the nine months ended September 30, 2009, we launched a business talk show called ValueRich TV, which is produced at a dedicated studio next door to our headquarters. Its purpose is to create a successful Wall Street based talk show that can be streamed over the internet for worldwide distribution. In January 2009, we purchased and closed on the building to be used as the studio.


In August 2008, we implemented a stock repurchase program for up to $400,000 shares of our common stock on the open market. However, our stock has become somewhat illiquid due to very light volume. To date, the $400,000 buy back program has resulted in only approximately $30,000 of stock being repurchased in the open market.


18

--------------------------------------------------------------------------------



Comparison of the Three Months Ended September 30, 2009 and 2008

Three months ended
September 30, 2009 Three months ended
September 30, 2008
Amount % of
Revenue Amount % of
Revenue
REVENUE $ 15,500 100.0 % $ 89,950 100.0 %

COST OF REVENUE - 0.0 % 1,560 1.7 %

GROSS PROFIT 15,500 100.0 % 88,390 98.3 %

OPERATING EXPENSES 187,109 1207.2 % 289,599 322.0 %

OTHER INCOME (EXPENSE) 98,477 635.3 % 13,696 15.2 %

NET LOSS (73,132) -471.8 % $ (187,513 ) -208.5% %



Revenue and Cost of Revenue


During the three months ended September 30, 2009, we generated $15,500 in revenue that arose primarily from consulting services we provided. During the same period of 2008 we had revenues of $89,950. During 2009, we launched ValueRich TV, which is produced at a dedicated studio next door to our headquarters. We have not yet earned revenue from ValueRichTV in 2009. We anticipate generating revenue from this line of business over the next twelve months as we continue to promote this product. Our total cost of revenue for the three months ended September 30, 2009 was $0 as compared to $1,560 for the three months ended September 30, 2008.


Operating Expenses


Total operating expenses decreased by $102,490 from $289,599 for the three months ended September 30, 2008 to $187,109 for the three months ended September 30, 2009. The decrease in total operating expenses was due to a decrease in salaries as a result of downsizing and a decrease in consulting services received.


Other Income (Expense)


Other income (expenses) during the three months ended September 30, 2009 as compared to September 30, 2008 increased by $84,781 from $13,696 for the three months ended September 30, 2008 to $98,477 for the same period in 2009. This increase is primarily attributable to unrealized gains on its investments in marketable securities during the three months ended September 30, 2009. During the fourth quarter 2008, the Company invested a substantial portion of its cash in marketable securities. During the three months ended September 30, 2009, the Company recognized $73,503 in unrealized gains from its trading securities.


Net Loss


Net loss for the quarter ended September 30, 2009 as compared to the period ended September 30, 2008 decreased from $187,513 to $73,132. The decrease was due to the decrease in operating expenses as a result of downsizing offset by an increase in unrealized gains in the investments in marketable securities.





19

--------------------------------------------------------------------------------




Comparison of the Nine Months Ended September 30, 2009 and 2008



Nine months ended
September 30, 2009 Nine months ended
September 30, 2008
Amount % of
Revenue Amount % of
Revenue
REVENUE $ 83,762 100.0 % $ 89,950 100.0 %

COST OF REVENUE - 0.0 % 7,876 8.8 %

GROSS PROFIT 83,762 100.0 % 82,074 91.2 %

OPERATING EXPENSES 756,358 903.0 % 1,000,448 1112.2 %

OTHER INCOME (EXPENSE) 152,683 182.3 % 108,813 121.0 %

NET LOSS (519,913) -620.7 % $ (809,561 ) -900.0 %



Revenue and Cost of Revenue


During the nine months ended September 30, 2009, we generated $83,762 in revenue that arose primarily from consulting services we provided. During the same period of 2008 we had revenues of $89,950. During the nine months ended September 30, 2009, we launched ValueRich TV, which is produced at a dedicated studio next door to our headquarters. We have not yet earned revenue from ValueRichTV in 2009. We anticipate generating revenue from this line of business over the next twelve months as we continue to aggressively promote this product. Our total cost of revenue for the nine months ended September 30, 2009 was $0 as compared to $7,876 for the nine months ended September 30, 2008.


Operating Expenses


Total operating expenses decreased by $244,090 from $1,000,448 for the nine months ended September 30, 2008 to $756,358 for the nine months ended September 30, 2009. The decrease in total operating expenses was primarily attributable to a decrease in consulting services received and salaries as a result in downsizing our workforce due to the change in our focus to the ValueRichTV platform.


Other Income (Expense)


Other income (expenses) during the nine months ended September 30, 2009 as compared to September 30, 2008 increased by $43,870 from $108,813 for the nine months ended September 30, 2008 to $152,683 for the same period in 2009. This increase is due to unrealized gains on marketable securities. During the fourth quarter of 2008, the Company invested a substantial portion of its cash in marketable securities. During the nine months ended September 30, 2009, the Company recognized $2,310 in unrealized gains from its trading securities, and $73,150 in realized gains from sales of its marketable securities.


Net Loss


Net loss for the nine months ended September 30, 2009 as compared to the period ended September 30, 2008 decreased from $809,561 to $519,913 primarily as a result of the decrease in professional services and staffing costs during the nine months ended September 30, 2009 as we have changed the focus of our core business operations to the ValueRichTV platform.





20

--------------------------------------------------------------------------------




Liquidity and Capital Resources


The following table sets forth a summary of our cash flows for the periods presented below:


Nine months ended September 30,
2009 2008
Net cash used in operating activities $ (589,969) $ (834,073)
Net cash provided by (used in) investing activities 961,476 (116,277)
Net cash provided by financing activities (9,500) (70,000)
Net decrease in cash and cash equivalents 362,007 (1,020,350)
Cash and cash equivalents at the end of the period $ 1,282,915 $ 2,548,185


For the nine months ended September 30, 2009 we had an increase in total cash resources of $362,077. The increase in cash was primarily due to sales of marketable securities and a corresponding gain on sale of $73,150.


We have spent, and expect to continue to spend, substantial amounts in connection with the implementation of our business strategy, including our revisions to our current lines of business and our future endeavors. Based on our current plans, we believe that our cash will be sufficient to enable us to meet our planned operating needs at least for the next 12 months. Because of current economic and market conditions and due to the unknown future of our nations’s economic health, we have taken prudent measures to manage our cash position and not force the growth of our core business.


Commitments and Contingencies


In January 2009, we entered into a one year lease agreement with Joseph C. Visconti, CEO and President, to lease a 1,750 square foot office facility for $3,190 per month ($38,280 per year) commencing January 1, 2009 and terminating on December 31, 2009.


Contractual Obligations


We have one $25,000 convertible note payable outstanding at September 30, 2009. The note was issued in October 2004, accrues interest at 6% per annum, and matured in December 2007. Other material terms of the convertible debt instruments include: 1) a conversion price of $0.60 per share; 2) a debt penalty to include the issuance of additional shares upon conversion totaling 10% of the shares into which the note may convert if the Company’s shares are not listed for public trading on or before October 1, 2004 and 3) a warrant to purchase the same number of shares into which the original principal amount could be converted at an exercise price of $2.00 per share. As the note is in default, we have classified the convertible note as short-term.


Off-Balance Sheet Arrangements


We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.


Critical Accounting Policies


The Company believes that the following critical accounting policies are affected by significant judgments and estimates used in the preparation of its consolidated financial statements.





21

--------------------------------------------------------------------------------




Fair Value of Financial Instruments and Concentrations


On January 1, 2008, we adopted FASB ASC 820-10, β€œFair Value Measurements and Disclosures.” FASB ASC 820-10 defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

· Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.


· Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.


· Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.


Stock-Based Compensation


We account for its stock-based compensation in accordance with FASB ASC 718 β€œCompensation-Stock Compensation,” We recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees, estimated using the Black-Scholes option pricing model. No options or warrants were exercised during the nine months ended September 30, 2009.


Recent Pronouncements


In May 2009, the FASB issued SFAS No. 165, β€œSubsequent Events” (β€œSFAS 165”) codified in FASB ASC 855-10-05, which provides guidance to establish general standards of accounting for and disclosures of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. FASB ASC 855-10-05 also requires entities to disclose the date through which subsequent events were evaluated as well as the rationale for why that date was selected. FASB ASC 855-10-05 is effective for interim and annual periods ending after June 15, 2009, and accordingly, we adopted this pronouncement during the second quarter of 2009. FASB ASC 855-10-05 requires that public entities evaluate subsequent events through the date that the financial statements are issued.

In June 2009, the FASB issued SFAS No. 166, β€œAccounting for Transfers of Financial Assets β€” an amendment of FASB Statement No. 140” (β€œSFAS 166”), codified as FASB ASC 860, which requires entities to provide more information regarding sales of securitized financial assets and similar transactions, particularly if the entity has continuing exposure to the risks related to transferred financial assets. FASB ASC 860 eliminates the concept of a β€œqualifying special-purpose entity,” changes the requirements for derecognizing financial assets and requires additional disclosures. FASB ASC 860 is effective for fiscal years beginning after November 15, 2009. The adoption of FASB ASC 860 did not have an impact on our financial condition, results of operations or cash flows.


In June 2009, the FASB issued SFAS No. 167, β€œAmendments to FASB Interpretation No. 46(R)” (β€œSFAS 167”), codified as FASB ASC 810-10, which modifies how a company determines when an entity that is insufficiently capitalized or is not controlled through voting (or similar rights) should be consolidated. FASB ASC 810-10 clarifies that the determination of whether a company is required to consolidate an entity is based on, among other things, an entity’s purpose and design and a company’s ability to direct the activities of the entity that most significantly impact the entity’s economic performance. FASB ASC 810-10 requires an ongoing reassessment of whether a company is the primary beneficiary of a variable interest entity. FASB ASC 810-10 also requires additional disclosures about a company’s involvement in variable interest entities and any significant changes in risk exposure due to that involvement. FASB ASC 810-10 is effective for fiscal years beginning after November 15, 2009. The adoption of FASB ASC 810-10 did not have an impact on our financial condition, results of operations or cash flows.






22

--------------------------------------------------------------------------------




In June 2009, the FASB issued FASB ASC 105, Generally Accepted Accounting Principles, which establishes the FASB Accounting Standards Codification as the sole source of authoritative generally accepted accounting principles. Pursuant to the provisions of FASB ASC 105, the Company has updated references to GAAP in its financial statements issued for the period ended September 30, 2009. The adoption of FASB ASC 105 did not impact our financial position or results of operations.


Item 3- Quantitive and Qualitative Disclosures About Market Risk


N/A


Item 4T – Controls and Procedures


Evaluation of Disclosure Controls and Procedures


The Company’s Chief Executive Officer and Chief Financial Officer has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2009. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer has concluded that, as of September 30, 2009, the Company’s disclosure controls and procedures were ineffective. This conclusion by the Company’s Chief Executive Officer and Chief Financial Officer does not relate to reporting periods after September 30, 2009. This conclusion is based upon material weaknesses of this Company’s disclosure controls and procedures that relate to the following:

1. Accounting and Finance Personnel Weaknesses – The Company’s current accounting staff is relatively small and the Company’s resources are limited given its size; and


2. Lack of Internal Audit Function – The Company lacks sufficient resources to perform the internal audit function.


3. Amendment to the Company’s Form 10-K for the year ended December 31, 2008 – The Company filed an amendment to its Annual Report on Form 10-K for the year ended December 31, 2008 (β€œOriginal Filing”), filed with the Securities and Exchange Commission on March 31, 2009, to revise certain disclosures. In its Original Filing, the Company failed to disclose the conclusions of the Company’s principal executive and financial officer regarding the effectiveness of the Company’s disclosure controls and procedures as of December 31, 2008. In addition, (a) the Original Filing stated that the Company believed the pending adoption of EITF 07-05 would have a material impact on the Company’s financial statement when, in fact, the Company believes the adoption of EITF 07-05 will not have such a material impact, (b) the Original Filing failed to (i) disclose the cost basis of the available-for-sale securities disclosed in Note 4 to the audited financial statements included in the Original Filing, (ii) clarify that unrealized gains on available-for-sale securities are recognized in the Company’s statements of shareholders’ equity, (iii) provide additional information regarding the specific transactions that resulted in realized gains and losses on market securities and (iv) provide additional information regarding the specific nature of the Company’s investment securities and their market performance during the periods presented.

In order to mitigate these material weaknesses to the fullest extent possible, all financial reports are reviewed by an outside accounting firm that is not our audit firm. All unexpected results are investigated. At any time, if it appears that any control can be implemented to continue to mitigate such weaknesses, it will be immediately implemented. The Company is in the process of complying with SOX 404 during 2009 and will be implementing additional internal controls over financial reporting and additional disclosure controls and procedures.



23

--------------------------------------------------------------------------------




Changes in Internal Control Over Financial Reporting


No change in the Company’s internal control over financial reporting occurred during the quarter ended September 30, 2009, that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.




PART II. OTHER INFORMATION


Item 1. Legal Proceedings


The Company knows of no material, existing or pending legal proceedings against it, nor is the Company involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of the Company’s directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to the company.


Item 1A. Risk Factors


This item is not applicable to smaller reporting companies.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds


None.


Item 3. Defaults Upon Senior Securities


None.


Item 4. Submission of Matters to a Vote of Security Holders


None.


Item 5. Other Information

None.


Item 6. Exhibits


Exhibit Description

31.1 Section 302 Certification of Principal Executive Officer and Principal Financial Officer.*
32.1 Certification of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.*




--------------------------------------------------------------------------------

* Filed herewith






24

--------------------------------------------------------------------------------







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

VALUERICH INC.

Date: November 19, 2009 By: /s/ Joseph C. Visconti
Joseph C. Visconti,
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial Officer)










25

--------------------------------------------------------------------------------


















































πŸ‘οΈ0
loniee loniee 15 years ago
only 2 or three of them riverfronts covers the cost of that deal
πŸ‘οΈ0
loniee loniee 15 years ago
These folks are smart...takeing their cash and buying in this market...a year or two that is pure gold...I have played this a few time the last couple of years and suprised it is still this far under the radar..
πŸ‘οΈ0
THUMBS THUMBS 15 years ago
ValueRich Subsidiary Acquires Certain Assets of the Tesoro Preserve Development
Jan 22, 2010 10:53:00 AM
Copyright Business Wire 2010


WEST PALM BEACH, Fla.--(BUSINESS WIRE)-- ValueRich, Inc. (NYSE Amex: IVA) announced today that VR Preserve Development, LLC ("VR Preserve"), our wholly owned subsidiary, acquired certain assets related to the Tesoro Preserve Development located in Port St. Lucie, Florida ("the Development"). The Tesoro Preserve Development is a private 341-acre community with 440 individual home sites of real property located on the St. Lucie River in St. Lucie County, Florida.

Included in the asset purchase was six (6) waterfront single-family residential lots, seventy-six (76) single family residential lots, approximately seven (7) acre commercially zoned parcel, and certain related Appurtenances, Improvements, Personal Property, Intangible Property, Assigned Agreements, Leases, Interests as Declarant under the Master Declaration, and Association Rights.

VR Preserve will become the Declarant of the Tesoro Preserve Development. As the Declarant of the development, the Company has the right to require homebuilders to enter into Developer's Homebuilding Royalty Agreements entitling the Company to certain development fees. As consideration for the acquisition, the Company paid $250,000 in cash. As additional consideration for the purchase, the Company entered into a Development Agreement under which it agreed to complete certain development work including construction of a social club, swimming pool and tennis courts. As required by the Development Agreement, VR Preserve deposited approximately $1,400,000 with an escrow agent representing the estimated costs to complete the work under the Development Agreement. The funds were lent to VR Preserve from ValueRich, Inc.

"I realize the purchase of the Tesoro Preserve assets is a shift in our business strategy, but the fact is that the financial structure in our country has changed, business strategies have shifted and our economy has new rules. There was over $30,000,000 worth of infrastructure put into The Tesoro Preserve Project by the original developer and this deal could only take place in the environment we are currently in. We are hopeful that we can integrate our media and production facilities into this deal to better market and communicate the story. The Tesoro Preserve development is a large project that has many moving parts, we believe that the development will yield years of results for our shareholders," said Joseph Visconti, CEO of ValueRich, Inc.

About ValueRich, Inc.

ValueRich, Inc. operates online media-based properties for corporate and financial professionals, it also has acquired certain assets of The Tesoro Preserve Development through VR Preserve Development, LLC, a wholly owned subsidiary of ValueRich, Inc. The Company's corporate mission is to utilize its assets to create shareholder value.

This press release contains statements, which may constitute ``forward-looking statements'' within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of ValueRich, Inc. And members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
πŸ‘οΈ0
Stock Stock 15 years ago
Company Profile for ValueRich, Inc.

ValueRich is a financial media company that assists small public companies with raising capital and attracting shareholders. ValueRich operates with several divisions named Wall Street HDTV, iValueRich and ValueRich TV, which is a web based 30 minute show that focuses on up and coming companies with a ground breaking technology or service that will change the way we live, work and play.

Company:
ValueRich, Inc.

Headquarters Address:
1804 North Dixie Highway
Suite A
West Palm Beach, FL 33407

Main Telephone:
561-370-3617

Website:
www.ivaluerich.com

Ticker/ISIN:
(AMEX:IVA)/US92046V1044

Type of Organization:
Public

Industry:
Public Relations/Investor Relations

Earnings Release Dates:
1st Quarter: May 12, 2009
2nd Quarter: August 12, 2009
3rd Quarter: November 12, 2009
4th Quarter: February 14, 2010

Key Executives:
CEO: Joseph Visconti

Executive

Contact:
Jane Ambrose
Phone:
561-370-3617
Email:
info@ivaluerich.com

http://ih.advfn.com/p.php?pid=nmona&cb=1244210492&article=37426687&symbol=A%5EIVA
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
Dang right! gratz bro! Thanks OM for the headsup
πŸ‘οΈ0
loniee loniee 16 years ago
.60 close at HODF very nice
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
WOW! Looks like she finally found her legs!
πŸ‘οΈ0
loniee loniee 16 years ago
was up to .4201...looks like someone got out
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
what just happened?
πŸ‘οΈ0
loniee loniee 16 years ago
getting quite a bit of love here today
πŸ‘οΈ0
loniee loniee 16 years ago
cooool
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
she's moving on up!
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
can anyone explain the way this has been trading?
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
100 shares brings this down 22%? lol, this thing moves on air.
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
whats going on here today. Nice gains!
πŸ‘οΈ0
OptionMonster OptionMonster 16 years ago
No problem>>Been watching this one for some time>>Good long term if you have the patience
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
well I misunderstood! Thanks for clearing that up!
πŸ‘οΈ0
OptionMonster OptionMonster 16 years ago
Right>>Says nothing about the authorized stock buyback by the company>>Just the agreement with that company
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
So this, " LLC have terminated their Stock Purchase Agreement effective immediately" does not refrence the stock buy back?
πŸ‘οΈ0
OptionMonster OptionMonster 16 years ago
This is still in play>>I see nothing stopping this>>

ValueRich, Inc. Announces Results of Operations for Second Quarter 2008 and Stock Buyback Program

ValueRich, Inc. (AMEX:IVA), a diversified financial media company, today announced the results of its operations for the three- and six-month periods ended June 30, 2008.

Net Loss for the quarter ended June 30, 2008 decreased to approximately $(190,000) from $(421,769) for the same period ended June 30, 2007. The decreased loss was primarily a result of a decrease in operating expenses and to a lesser extent professional fees resulting from a revision of the financial expo line of business and shifting ValueRich magazine to an online publication. Due to the overall market conditions and current economic environment ValueRich, Inc. generated no revenue for the three months ended June 30, 2008.

ValueRich also announced today that its board of directors has authorized the repurchase of up to $400,000 of ValueRich (AMEX:IVA) common stock. Shares may be repurchased under the program from time to time in the open market, in privately negotiated transactions or in other ways. ValueRich will decide on purchases based on market conditions and other relevant considerations.

“We believe the current valuation of ValueRich common shares makes the repurchase of our equity a solid investment for the company and will be accretive to shareholder value,” said Joseph Visconti, President and CEO of ValueRich, Inc.



πŸ‘οΈ0
OptionMonster OptionMonster 16 years ago
This is what got cancelled>>>

ValueRich Announces Marketing and Technology Agreement with Full-Service Broker Dealer Syndicated Capital and Terminates Stock P




ValueRich, Inc. (AMEX:IVA), and Starlight Investments, LLC have terminated their Stock Purchase Agreement effective immediately. The parties, however, plan to explore other strategic business alliances in the future.

On August 21, 2008, ValueRich entered into a Marketing and Technology Agreement with Syndicated Capital, a full service broker dealer. Syndicated Capital will provide an array of full-service brokerage services including but not limited to, an online trading platform, respective clearing services, trading services, back office support, administration, compliance and customer support. Syndicated Capital will be providing the online trading platform and related services through their clearing agent, Pershing LLC.

Joseph Visconti, CEO of ValueRich stated, “Our relationship with Syndicated Capital will allow ValueRich to use its marketing and technology platform to assist companies in raising capital, going public and attracting shareholders. By leveraging our technology, the ValueRich brand asset and our network of qualified professionals with Syndicated Capital’s innovative online banking platform, we are hoping to change the way small-cap funding is accomplished.” About ValueRich, ValueRich, Inc. operates various online and offline media-based properties for corporate and financial professionals, including ValueRich magazine and the industry-wide online financial community iValueRich.com. The Company's corporate mission is to create an active community of financial professionals and micro-cap public company executives through its integrated portfolio of products and services.


πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
they cnxed that idea...
πŸ‘οΈ0
OptionMonster OptionMonster 16 years ago
Company said they would be buying back stock
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
wow what a hit. 35k volume. maybe she'll start to move now, once the bid moves up.
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
we'll have to see how things play out and the companies plans...
πŸ‘οΈ0
stocksniperz stocksniperz 16 years ago
wow. I wonder where this will go...
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock